Virus News and Research

Latest Virus News and Research

Study highlights the critical role of junk DNA in mammalian development

Nearly half of our DNA has been written off as junk, the discards of evolution: sidelined or broken genes, viruses that got stuck in our genome and were dismembered or silenced, none of it relevant to the human organism or human evolution.

19 Oct 2021

Scientists scan 110 natural compounds for SARS-CoV-2 antiviral potential

Phytochemicals are plant-derived molecules from medicinal plants that act as a prominent reservoir for treating a wide range of viral infections. In a new study, published in the journal Scientific Reports, scientists adopted a computational approach to identify Mpro inhibitors.

19 Oct 2021

SARS-CoV-2 antibodies detected in breast milk of vaccinated mothers

Now, a new medRxiv* preprint study finds mothers vaccinated either one of the messenger RNA (mRNA) vaccines transferred neutralizing antibodies and cytokines, including interferon-gamma (IFNγ), to a breastfeeding child. Additionally, the humoral response in breastmilk was effective in neutralizing four variants of concern.

18 Oct 2021

Wastewater from flights can help detect COVID-19 before passengers show symptoms

Researchers from The University of Queensland and Australia's national science agency CSIRO have found SARS-CoV-2 virus in wastewater samples from long haul flights of returning Aussies, proving they can detect it before passengers show symptoms.

18 Oct 2021

Immune system activation is modulated according to the time of day

Circadian clocks, which regulate most of the physiological processes of living beings over a rhythm of about 24 hours, are one of the most fundamental biological mechanisms.

18 Oct 2021

Modelling suggests fall in acute admissions with mass COVID-19 vaccinations

A new study explores the utility of modeling the impact of mass vaccination on the number of hospital beds occupied by acute COVID-19 cases.

18 Oct 2021

Telehealth to the rescue for children’s mental health during COVID

A new study concludes that the lack of transportation led to impairments in child mental health services.

18 Oct 2021

Factors contributing to a weak antibody response to the Pfizer COVID-19 vaccine

A new study discusses risk factors for the failure of seroconversion following full vaccination with the COVID-19 Pfizer vaccine.

18 Oct 2021

Interferon beta-1a plus remdesivir not superior to remdesivir alone in hospitalized COVID-19 patients

A clinical trial has found that treatment with the immunomodulator interferon beta-1a plus the antiviral remdesivir was not superior to treatment with remdesivir alone in hospitalized adults with COVID-19 pneumonia.

18 Oct 2021

Study uncovers neuronal circuitry that may play a key role in mediating pain-induced anhedonia

A new study published today in Nature Neuroscience has uncovered neuronal circuitry in the brain of rodents that may play an important role in mediating pain-induced anhedonia - a decrease in motivation to perform reward-driven behaviors.

18 Oct 2021

Neuroscientists discover specific brain circuit that triggers cocaine relapse in mice

Relapse is a common feature of addiction recovery – two in three patients treated for substance use disorder in the United States relapse within 12 months, according to the Journal of the American Medical Association.

18 Oct 2021

What will it take to boost vaccinations? The scene from Kentucky’s back roads

In the end it was the delta variant that drove Rose Mitchell, 89, down the winding mountain road to the Full Gospel Church of Jesus Christ to get the shot. Her pastor, Billy Joe Lewis, had told his congregation that, No, ma'am, a covid vaccine would not leave the "mark of the beast" nor rewrite their genetic codes.

18 Oct 2021

How can framing COVID-19 vaccine side-effects affect an individual's willingness to be vaccinated?

Researchers from the University of Munich have investigated how framing vaccine side-effects can affect an individual's willingness to be vaccinated.

18 Oct 2021

Study assesses T-cell responses directed against highly conserved regions of SARS-CoV-2

The study aimed to assess whether highly conserved regions within coronaviruses harbor CD8+ T-cell epitopes, capable of being cross-recognized between different coronaviruses.

18 Oct 2021

Surveillance, prevention of COVID-19 and seasonal influenza in Europe

In the northern hemisphere, annual seasonal influenza activity usually causes a high burden of disease during the winter months.

18 Oct 2021

Researchers report long-lasting effects of gene therapy in children with deadly immune disorder

Over a decade ago, UCLA physician-scientists began using a pioneering gene therapy they developed to treat children born with a rare and deadly immune system disorder.

18 Oct 2021

Coronavirus vaccines and prior infections can provide broad immunity against similar viruses

Northwestern Medicine scientists have shown for the first time that coronavirus vaccines and prior coronavirus infections can provide broad immunity against other, similar coronaviruses. The findings build a rationale for universal coronavirus vaccines that could prove useful in the face of future epidemics.

18 Oct 2021

Study provides the most detailed analysis of England's SARS-CoV-2 genomic surveillance information

The Covid-19 crisis that gripped the UK between September 2020 and June 2021 can be thought of as a series of overlapping epidemics, rather than a single event, say researchers at the Wellcome Sanger Institute, EMBL's European Bioinformatics Institute (EMBL-EBI) and their collaborators.

18 Oct 2021

Delta and Delta Plus infect lung cells with higher efficiency than the original virus, research shows

The emergence of new SARS-CoV-2 variants that can spread rapidly and undermine vaccine-induced immunity threatens the end of the COVID-19 pandemic. The delta variant (B.1.617.2) emerged in India and subsequently spread globally within a short time period. Also in Germany, almost all recent infections are due to this variant.

18 Oct 2021

New technology to detect SARS-COV-2 using sugars rather than antibodies

Researchers at the University of Warwick, Iceni Diagnostics Ltd and University Hospitals Coventry and Warwickshire (UHCW) NHS Trust have demonstrated their technology to detect SARS-COV-2 using sugars rather than antibodies.

18 Oct 2021

Virus News and Research

Latest Virus News and Research

Study highlights the critical role of junk DNA in mammalian development

Scientists scan 110 natural compounds for SARS-CoV-2 antiviral potential

SARS-CoV-2 antibodies detected in breast milk of vaccinated mothers

Wastewater from flights can help detect COVID-19 before passengers show symptoms

Immune system activation is modulated according to the time of day

Modelling suggests fall in acute admissions with mass COVID-19 vaccinations

Telehealth to the rescue for children’s mental health during COVID

Factors contributing to a weak antibody response to the Pfizer COVID-19 vaccine

Interferon beta-1a plus remdesivir not superior to remdesivir alone in hospitalized COVID-19 patients

Study uncovers neuronal circuitry that may play a key role in mediating pain-induced anhedonia

Neuroscientists discover specific brain circuit that triggers cocaine relapse in mice

What will it take to boost vaccinations? The scene from Kentucky’s back roads

How can framing COVID-19 vaccine side-effects affect an individual's willingness to be vaccinated?

Study assesses T-cell responses directed against highly conserved regions of SARS-CoV-2

Surveillance, prevention of COVID-19 and seasonal influenza in Europe

Researchers report long-lasting effects of gene therapy in children with deadly immune disorder

Coronavirus vaccines and prior infections can provide broad immunity against similar viruses

Study provides the most detailed analysis of England's SARS-CoV-2 genomic surveillance information

Delta and Delta Plus infect lung cells with higher efficiency than the original virus, research shows

New technology to detect SARS-COV-2 using sugars rather than antibodies

A new way of characterising biomolecules eBook

Exploring the role of confocal-based high-content imaging in advancing core facilities

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Virus News and Research

Latest Virus News and Research

A new way of characterising biomolecules eBook

Exploring the role of confocal-based high-content imaging in advancing core facilities

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Newsletters you may be interested in